Daniel DeAngelo

SPORE in Leukemia

National Cancer Institute · P50

Project lead · $87.5K · Dana-Farber Cancer Inst

Development of Novel Therapeutic Strategies in Human Leukemias

National Cancer Institute · P01

Project lead · $199.7K · Dana-Farber Cancer Inst

SPARK-ALL: Calaspargase Pegol in Adults With ALL

Principal investigator · Terminated · Phase 2, Phase 3

Institut de Recherches Internationales Servier

Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia

Principal investigator · Terminated · Phase 3

GlycoMimetics Incorporated

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Principal investigator · Completed · Phase 1, Phase 2

GlycoMimetics Incorporated

ALL Adult Consortium Trial: Adult ALL Trial

Principal investigator · Completed · Phase 2

Dana-Farber Cancer Institute